Kera Capital Partners Significantly Boosts Stakes in Centene, Goldman Sachs, and Other Key Companies

Kera Capital Partners reported that after its 90.1% Centene stake increase, it held 25,831 Centene shares (adding 12,243 shares) worth $1,119,000 in its latest SEC filing; the article also notes 93.63% of Centene stock is held by hedge funds and other institutional investors.
For Thornburg Income Builder Opportunities Trust, Kera said it owned 434,901 shares after acquiring 33,282 additional shares; the stake is described as about 1.2% of its portfolio and its 22nd-largest holding, worth $9,216,000.
The Corning item included precise insider trading details: CEO Wendell P. Weeks sold 100,000 shares on June 9 at an average price of $186.46 (total $18,646,000), and after the sale directly owned 908,353 shares (the article describes this as a 9.92% change).
On Allison Transmission analyst revisions, the article specifically cites Morgan Stanley raising its price objective from $117.00 to $126.00 while assigning an “equal weight” rating; it also states hedge funds and other institutional investors own 96.90% of Allison Transmission stock.
Kera Capital Partners, a San Jose-based investment firm managing roughly $1.356 billion in assets, sharply boosted its stakes in several major companies during Q4 2025, according to SEC filings. Its biggest moves included a 90.1% jump in Centene shares, a 95.7% increase in Goldman Sachs, and a 139.2% surge in Allison Transmission — all disclosed in February 2026 Ticker Report filings.
The moves signal a strategic shift toward healthcare and finance stocks. At the same time, a top Corning executive sold $18.6 million in shares, raising questions about whether some of these high-flying stocks have peaked.
Kera added 12,243 shares of Centene in Q4 2025, bringing its total to 25,831 shares worth $1,119,000, per Ticker Report. That is a 90.1% increase in one quarter. The firm also nearly doubled its Goldman Sachs position, lifting it 95.7%. Both moves point to a firm betting on value in healthcare and finance at a time when tech stocks dominate headlines.
Centene is no small bet in the institutional world. Hedge funds and other big investors already own 93.63% of Centene's stock, according to Ticker Report. That level of ownership means the stock can move fast when large funds shift positions in either direction.
Kera's most aggressive move was in Allison Transmission, where it grew its position by 139.2%. Institutional investors already own 96.90% of Allison stock, per Ticker Report. The heavy-duty transmission maker has been expanding into electrification and automation, including a new venture fund called Allison Ventures and an acquisition of Dana Incorporated's off-highway business in early 2026.
Analysts are cautiously positive. Morgan Stanley raised its Allison price target from $117.00 to $126.00 in May 2026. But analyst Angel Castillo kept the rating at "Equal Weight," meaning the bank sees the stock as fairly valued rather than a screaming buy. Raymond James takes a stronger view, holding a "Buy" rating on the stock.
While Kera nudged its Corning stake up just 2.7%, the company's own CEO made a much louder statement. Wendell P. Weeks sold 100,000 shares on June 9, 2026, at an average price of $186.46 per share — a total of $18,646,000. After the sale, he directly owned 908,353 shares. That is a 9.92% cut to his personal stake, according to SEC filings reviewed by research firm Investing.com.
Corning stock had surged roughly 273% in the 12 months before the sale, driven by demand for specialty glass used in AI data centers. But Investing.com noted the stock looks "overvalued relative to its Fair Value," trading at a price-to-earnings ratio of 83.31. Weeks's exit was the largest of at least 16 insider sales over six months — a pattern that value analysts flag as a warning sign.
Away from the bigger headlines, Kera also grew its position in Thornburg Income Builder Opportunities Trust by 8.3%, adding 33,282 shares to reach 434,901 total. The holding is worth $9,216,000 and ranks as Kera's 22nd-largest position, making up about 1.2% of its total portfolio, per Ticker Report. The trust focuses on income-generating investments, fitting a broader defensive tilt in Kera's strategy.
Taken together, Kera's Q4 moves show a firm rotating into sectors seen as more stable — healthcare, finance, and income funds — while still keeping speculative bets like Allison Transmission. The next real test comes when Q1 2026 13F filings reveal whether Kera held its positions or trimmed after the market's volatile start to 2026.
Publishers
16
Articles
9
Reach
25